ImmuPharma plc

ImmuPharma plc - PE Ratioverified

IMMPF

Price:

$0.085

Market Cap:

$19.86M

ImmuPharma plc, established in London, United Kingdom, in 1999, is a biopharmaceutical company dedicated to discovering and advancing peptide-based therapeutics. These treatments are focused on tackling conditions related to autoimmunity, inflammation, and various infections. The company's primary drug candidate, Lupuzor, an autophagy immunomodulator, is presently in Phase III clinical trials for the management of lupus, a chronic autoimmune inflammatory disorder. Additional product developments include BioAMB, a peptide-based medication for fungal infections, particularly those caused by the aspergillus family, and BioCin, a peptide-derived antibacterial agent designated for high medical ne...[Read more]

Industry

Biotechnology

IPO Date

2017-02-08

Stock Exchange

OTC

Ticker

IMMPF

The PE Ratio as of June 2026 (TTM) for ImmuPharma plc (IMMPF) is -2.13

According to ImmuPharma plc’s latest financial reports and current stock price. The company's current PE Ratio is -2.13. This represents a change of -105.79% compared to the average of 36.69 of the last 4 quarters.

ImmuPharma plc (IMMPF) Historical PE Ratio (quarterly & annually)

How has IMMPF PE Ratio performed in the past?

The mean historical PE Ratio of ImmuPharma plc over the last ten years is -8.57. The current -2.13 PE Ratio has changed 2.38% with respect to the historical average. Over the past ten years (40 quarters), IMMPF's PE Ratio was at its highest in in the December 2025 quarter at 155.00. The PE Ratio was at its lowest in in the December 2017 quarter at -39.05.

Quarterly (TTM)
Annual

Average

-8.57

Median

-3.08

Minimum

-39.79

Maximum

-1.46

ImmuPharma plc (IMMPF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ImmuPharma plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 730.91%

Maximum Annual PE Ratio = -1.46

Minimum Annual Increase = -94.31%

Minimum Annual PE Ratio = -39.79

Quarterly (TTM)
Annual
YearPE RatioChange
2025-16.76730.91%
2024-2.02-2.19%
2023-2.0641.18%
2022-1.46-28.09%
2021-2.03-47.82%
2020-3.89-2.94%
2019-4.0177.12%
2018-2.26-94.31%
2017-39.79247.39%
2016-11.4567.99%

ImmuPharma plc (IMMPF) Average PE Ratio

How has IMMPF PE Ratio performed in the past?

The current PE Ratio of ImmuPharma plc (IMMPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.95

5-year avg

-4.87

10-year avg

-8.57

ImmuPharma plc (IMMPF) PE Ratio vs. Peers

How is IMMPF’s PE Ratio compared to its peers?

ImmuPharma plc’s PE Ratio is greater than IntelGenx Technologies Corp. (-2.99), less than LakeShore Biopharma Co., Ltd (-0.48), less than IBEX Technologies Inc. (9.23), greater than OKYO Pharma Limited (-12.90), greater than Kadimastem Ltd (-2.35), greater than Alpha Cognition Inc. (-39.22), greater than Small Pharma Inc. (-2.23), greater than Organicell Regenerative Medicine, Inc. (-4.73), greater than Generation Hemp, Inc. (-3.88), less than Chill Brands Group PLC (-0.00),

Build a custom stock screener for ImmuPharma plc (IMMPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuPharma plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmuPharma plc (IMMPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmuPharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is ImmuPharma plc's PE Ratio?

How is the PE Ratio calculated for ImmuPharma plc (IMMPF)?

What is the highest PE Ratio for ImmuPharma plc (IMMPF)?

What is the 3-year average PE Ratio for ImmuPharma plc (IMMPF)?

What is the 5-year average PE Ratio for ImmuPharma plc (IMMPF)?

How does the current PE Ratio for ImmuPharma plc (IMMPF) compare to its historical average?